Integra LifeSciences Holdings Corporation Announces Launch of New Cortical Stimulator for Mapping Brain Functions in Cancer and Epilepsy Patients

PLAINSBORO, N.J., Sept. 21, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced the release of the OCS2 Ojemann Cortical Stimulator at this week’s annual meeting of the Congress of Neurological Surgeons in San Diego, CA. The OCS2 Ojemann Cortical Stimulator has an FDA clearance in the United States and a CE Mark Certification in the European Union.

MORE ON THIS TOPIC